SE539930C2

SE539930C2 - Dry powder inhaler

Info

Publication number: SE539930C2
Application number: SE1450411A
Authority: SE
Inventors: Lastow Orest; Arvidsson Lars; Lundgren Johan
Original assignee: Iconovo Ab
Priority date: 2014-04-03
Filing date: 2014-04-03
Publication date: 2018-01-23
Also published as: WO2015150519A1; SE1450411A1

Abstract

14 ABSTRACT A dry powder inhaler (100) comprising at least one inlet (101), at least one outlet (102), and a dosage communication (107) between said at least one inlet (101)and said at least one outlet (102), is provided. The inhaler (100) also comprises a firstmedicament reserVoir (109) and a dosage mechanism (104, 108) for arranging at leastone dose of a medicament from said first medicament reserVoir (109) between the inlet(101) and the outlet (102), such that said at least one dose may be delivered uponinhalation at said outlet (102). The dosage mechanism (104, 108) comprises a dose disc(104) with at least one opening (108), wherein the dose disc (104) may be rotatedbetween a dose collecting position, wherein the opening (108) is positioned in thereserVoir (109), and a dose administering position, wherein the opening (108)communicate with said dosage communication (107). At least one medicament scraper(113) is suspended in the reserVoir (109), such that the scraper (113) bear upon the dosedisc (104). To be published with Fig. 1

Description

DRY POWDER INHALER Field of the Invention This invention pertains in general to the field of medicament inhalers, andmore particularly to dry powder inhalers. The inhaler comprises at least one air inlet andat least one air outlet, and a reservoir for housing a dry powder drug, the inhaler havingan airﬂow from the at least one air inlet to the at least one outlet during inhalation by auser at said at least one outlet, to deliver said dry powder drug during inhalation by the USCT.

Background of the Invention In the pharrnaceutical field, with respect to treatment of respiratory and/orother diseases, inhalers have been widely used. Numerous drugs, medications and othersubstances are inhaled into the lungs for rapid absorption in the blood stream and forlocal action in the lung with such inhalers.

Inhaled drugs fall into two main categories, in form of liquids, includingsuspensions, and powders. The choice of category depends on the characteristics of thedrugs, medications, etc., to be inhaled.

The most common type of inhaler is the pressurized metered-dose inhaler. Inthis type of inhaler medication is most commonly stored in solution in a pressurizedcanister that contains a propellant, although it may also be a suspension. The canister isattached to a plastic, hand-operated actuator. On activation, the metered-dose inhalerreleases a fixed dose of medication in aerosol form.

Another kind of inhaler is a nebulizer, which supply medication as an aerosolcreated from an aqueous forrnulation.

The kind referred to herein is yet another type, in form of a dry powder inhaler.A dry powder inhaler releases a pre-metered, capsuled, dose or a device-metered doseof powdered medication that is inhaled through the inhaler. Inhalers with device-metered dose of powdered medication is norrnally inhalers with medication reservoir,containing powdered medication, from which metered doses are withdrawn through the use of different dose metering arrangements, said doses then being inhaled.

Dry powder inhalers need to deliver a particle size that is predominantly below5 microns, and preferably between 1 micron and 3.3 microns, for maximumeffectiveness. Such small particles are, however, very cohesive due to high surfaceenergy. Agglomeration may be worsened by moisture, and when the medicationcomprises more than one active substance, since the different active substances mayhave such properties as to form agglomerations with each other or with pharrnaceuticalcarriers etc. Agglomeration of small particles is a problem which results in the activeparticles leaving the inhaler as large agglomerates.

EP0237507 discloses one such powder inhaler with a device metered dose,comprising a medicament chamber, a dosing mechanism, and a ﬂow path from an airinlet to an air/medicament outlet. In the ﬂow path deﬂectors are arranged, to increasedeaggregation of medicament. However, this device is limited to medicaments havingone active substance or active substances that are compatible with each other duringstoring. Additionally, medicament will accumulate at the deﬂectors, decreasinguniforrnity of dosage.

An additional problem of the prior art inhalers is that they are either suitablefor micronized forrnulations or carrier based forrnulations - never both or combinationsof these.

In view of these drawbacks and limitations of the prior art, what is needed is adry powder inhaler device in which effective and satisfactory dispersion of the drypowder is obtained, which inhaler can administer medicament comprising substanceswhich are incompatible in mixture, and an inhaler with increased deaggregation and amore uniform dosage, as well as an inhaler which is suitable for both micronized formulations and/or carrier based forrnulations.

Summary of the Invention Accordingly, the present invention preferably seeks to mitigate, alleviate oreliminate one or more of the above-identiﬁed deficiencies in the art and disadvantagessingly or in any combination and solves at least the above mentioned problems byproviding a dry powder inhaler comprising: at least one inlet, at least one outlet, and adosage communication between said at least one inlet and said at least one outlet; a firstmedicament reservoir; a dosage mechanism for arranging at least one dose of a medicament from said first medicament reservoir between the inlet and the outlet, such that said at least one dose may be delivered upon inhalation at said outlet, wherein thedosage mechanism comprises a dose disc with at least one opening, wherein the dosedisc may be rotated between a dose collecting position, wherein the opening ispositioned in the reservoir, and a dose administering position, wherein the openingcommunicate with said dosage communication; wherein at least one medicamentscraper is suspended in the reservoir, such that the scraper bear upon the dose disc.Further advantageous embodiments are disclosed in the appended and dependent patent claims.

Brief Description of the Drawings These and other aspects, features and advantages of which the invention iscapable will be apparent and elucidated from the following description of embodimentsof the present invention, reference being made to the accompanying drawings, in which Fig. l is a cross sectional view along a longitudinal axis of an inhaler accordingto one embodiment in the dose administering position of the present invention; Fig. 2 is a perspective and cross sectional view of an inhaler according to oneembodiment of the present invention; Fig. 3 is a perspective and cross sectional view of an inhaler according to oneembodiment of the present invention, focusing on arrangement of openings in dose disc; Fig. 4 is a perspective and cross sectional view of an inhaler according to oneembodiment of the present invention, focusing on arrangement of openings in dose disc; Fig. 5 is a perspective and cross sectional view of an inhaler according to oneembodiment of the present invention, focusing on arrangement of medicament scraperover opening in dose disc; Fig. 6 is a perspective and cross sectional view of an inhaler according to oneembodiment of the present invention, focusing on arrangement of medicament scraperand medicament in opening; Fig. 7 is a cross sectional view along a longitudinal axis of an inhaler accordingto an embodiment of the present invention, focusing on arrangement of medicamentscraper over opening in dose disc; and Fig. 8 is a cross sectional view along a longitudinal axis of an inhaler accordingto one embodiment, wherein the air and air/medicament flows through this inhaler is disclosed.

Description of embodiments The following description focuses on an embodiment of the present inventionapplicable to a medicament inhaler, and in particular to a dry powder drug inhaler withmore than one medicament reservoir, such as two medicament conatiners. However, itwill be appreciated that the invention is not limited to this application but may beapplied to many other inhalers having an inlet and an outlet, as well as a medicamentreservoir.

Figs. 1 to 7 illustrate a dry powder drug inhaler 100. The dry powder druginhaler 100 comprises air inlets 101 and an air outlet 102. The outlet 102 is arranged ata first end of the dry powder drug inhaler 100, while the inlets 101 is arranged at a zonein an opposite second end of the dry powder drug inhaler 100. The outlet 102 isarranged centrally, along the longitudinal axis of the dry powder drug inhaler 100. Theinlets 101 may be arranged at a radial, in relation to the longitudinal axis of the drypowder drug inhaler 100, periphery of the dry powder inhaler 100, such that the inlets101 lead inhaled air transversally and radially towards the central portion of the drypowder inhaler 100.

As disclosed in the embodiment according to Fig. 4, which will be furtherdescribed below, the inlets 101 may however also be positioned with a direction beingparallel with the central axis of the dry powder inhaler 100.

The number of inlets and outlets may be different from what is disclosed inFigs. 1 to 4. The number of inlets may for example be adjusted in accordance withneeds and specific inhaler design, such that a number of smaller inlets, for reducingpressure fall over the inhaler, are arranged circumferentially of the dry powder ir1haler100. This is not shown. In a corresponding manner the number of air outlets may beadjusted in accordance with needs and specific inhaler design.

The different parts of the dry powder inhaler 100 may be manufactured in asuitable material, such as injection moldable plastics, such as therrnoplastics.

The dry powder inhaler 100 comprises three major parts in form of an upperproximal reservoir housing 103, a dose disc 104, and a lower distal twister 105. Thereservoir housing 103 and the twister cooperates so as to house the dose disc 104 inbetween these two. The twister 105 cooperates with the dose disc 104, such that the dose disc 104 may be rotated, via rotation and twisting of the twister 105, between a dose administering position and a dose collecting position. This may be accomplishedby interconnecting the dose disc 104 and the twister 105 via interconnecting groovesand ribs, or letting the twister 105 extend longitudinally centrally of the dose disc 104and connected thereto, such as disclo sed for example in Fig. 1. Preferably, the rotationof the dose disc 104 has two end positions, corresponding to the dose administeringposition and the dose collecting position, in its relation with the reservoir housing 103,in a known manner.

In the dose administering position, the inlets 101 are in ﬂuid communicationwith a mixing and deaggregation chamber 106 via dosage communications 107. Thedosage communications 107 then run through openings 108 in the dose disc 104. Hence,the openings 108, in the dose administering position, is superimposed thecommunications 107. When rotating the dose disc 104 into a dose collecting position,the openings 108 are rotated away from ﬂuid communication with the inlets 101 and thechamber 106. Instead, the openings 108 are rotated into medicament reservoirs 109,110, wherein the openings 108 may collect a medicament housed in the reservoirs 109,110. The medicament contained in the medicament reservoir 109 may be a medicamentdifferent from the medicament contained in the medicament reservoir 110. Due to thetwo reservoirs 109, 110, the inhaler 100 may deliver two substances in one inhalation,said two substances otherwise being incompatible, meaning that these two substancesnot would be possible to be comprised in one joint reservoir, such that a dry powderinhaler device 100 in which effective and satisfactory dispersion of the dry powder isobtained, which inhaler 100 can administer medicament comprising substances whichcan be incompatible in mixture or for other reasons are preferred to have in separatereservoirs.

It is possible to arrange the dose disc 104 and the openings 108 thereof suchthat when a first set of two openings 108 are superimposed the communications 107, i.e.in a dose administering position, a second set of two openings 108 are positioned in themedicament reservoirs 109, 110, respectively. Additionally, the distribution of theopenings 108 on the dose disc 104 is such that the dose disc may be rotated in onedirection only, which means that when the second set of two openings 108 aresuperimposed the communications 107, the first set of openings 108 are positioned inthe medicament reservoirs 109, 110, respectively. It is also possible to rotate the dosedisc 104 in a first direction to superimpose openings 108 over communications 107 indose administering position, and then rotate the dose disc 104 in the opposite direction into the dose collecting position, to thereafter again rotate the dose disc in the first direction into the dose administering position. When the dose disc 104 is rotated in afirst direction into the dose administering position and the opposite direction into thedose collecting position, the dose disc 104 may have rotational stops in the doseadministering position and the dose collecting position, respectively, to ensure goodsuperimposition over communications 107 and positioning in the medicament reservoirs109, 110, respectively.

It is also envisioned to provide the inhaler with more than two, such as three,four, five, or six, reservoirs 109, 110, with the same arrangement of inlets, outlets,communications, dose disc, openings etc., within the ambit of the present invention.

It is also envisioned that the inhaler 100 may be provided with a differentdosage mechanism than the one disclosed above, such as for example electrical drive ofdifferent parts, and using paddles instead of dose disc 4. However, the use of the dosedisc 104 and its cooperation with the twister 105 and the reservoirs 109, 110 allows fora very cost effective solution, while simultaneously ensuring a high dose accuracy andthe other benefits disclosed herein.

The dosage communications 107 are - in the embodiment disclosed in Fig. 1 -S-shaped. The S-shape is such that that the communications 107 starts at inlets 101 andextend downstream (during inhalation) in a central and transversal direction, where afterthey bend downwards and distally to extend in a longitudinal and distal direction to - inthe dose administering position - pass through the openings 108. In this way, whenmedicament is positioned in the openings 108, the change of air ﬂow direction willincrease the turbulence of the air flow, which will facilitate initial deaggregation of themedicament in the openings 108. This ensures that the all the medicament in theopenings 108 will follow the air flow in the communications into the chamber 106, andnot partly remain in the openings 108. Downstream (again during inhalation) theopenings 108, the communications 107 again bend to be directed into a central andtransversal direction, to exit into the chamber 106. Distally below the openings 108,when the communications 107 bend centrally and transversally, ledges 111 are formed.These ledges 111 ensures that medicament intended to be held in the openings 108 untilinhalation, which medicament may fall down, still may follow the inhaled air into thechamber 106. This means for example that the reservoirs 109, 110 may comprise a drypowder medicament in form of both a dry powder medicament in form of a micronizedformulation or a carrier based forrnulation, or mixtures thereof. The inhaler 100 may then for example comprise a dry powder medicament in form of a micronized formulation in the first reservoir 109 and a dry powder medicament in form of a carrierbased forrnulation in the second reservoir 1 10.

The directions of the two communications 107 when entering chamber 106 arearranged such that the air flows, and hence medicament ﬂows during inhalation, whenthe inhaler 100 is in a dose administering position, intersecting, such as to cross eachother or coincide with each other. The ﬂow directions from the communications 107will coincide with each other when they are arranged on opposing sides of the chamber106. The ﬂow directions from the communications will cross each other when thesedirections are angled in relation to each other but when both are directed towards thecentral longitudinal axis of the inhaler 100. In this way, the medicament in themedicament ﬂows will physically interact to increase deaggregation of themedicaments, which may increase dose uniformity, since the need for deﬂectors then isdecreased. This feature also adds the possibility to combine or adapt the inhaler 100 fordeliverance of micronized forrnulations and/or carrier based forrnulation. Of course, italso possible to combine the feature of crossing or coinciding ﬂows from the twocommunications 107 with deﬂectors, even though the need thereof is decreased.

Depending on the medicament to be administered, and the forrnulation thereof,the openings 108 may be more than one opening 108 per communication 107, such as aset of openings 108, as disclosed in Fig. 4. Some medicaments have other aggregationcharacteristics, making it difficult to retain the medicament as a “plug” in the opening108. Then, it may be preferable to make several openings 108 with a relatively smallerdiameter. Altematively, this can be to deliver a smaller amount of powder. This featurealso adds the possibility to combine or adapt the inhaler 100 for deliverance ofmicronized forrnulations and/or carrier based formulation.

During inhalation, the medicament will then follow the air ﬂow through thecommunications 107, into the chamber 106, wherein the air/medicament streams fromthe different communications 107 will cross, such that the medicament agglomerateswill collide to increase deaggregation, where after a jet stream of f1nely dispersedmedicament and air will continue through an inhalation chimney 112 out of theinhalator 100 through outlet 102, into the lungs of the user. The chimney 112 increasesjet formation, allowing for a maintained low aggregation of medicament, henceincreasing potential of medicament to reach out far in the lungs of the patient. Thechimney is generally tubular, but could optionally be provided with deﬂectors, tofurther increase jet creation. Such deﬂectors could be bumps or spiral-shaped ridges, extending along the length of the chimney from the chamber 106 to the outlet 102. The chimney 112 does not necessarily have to be directed upwardly; it can just as well bedirected downwardly or to the sides, whereby the outlet 102 naturally instead also ispositioned at the bottom or on the sides, respectively. Additionally, the chimney 112does not have to be generally tubular, but could be bent or sinus-shaped, depending onwhere on the inhaler 100 it is preferred to position the outlet 112. For ﬂowcharacteristics and dose reliability and maintenance, it is however preferred to have itdirected upwardly and generally tubular with optional deﬂectors. The general shape ofthe chimney 112 may also be such as to have differences in cross-sectional area, such ascone-shaped. In this way, the ﬂow velocity in the chimney may be regulated, so as tohelp in deaggregation at chosen parts.

As disclosed in Figs. 2 to 7, the reservoirs 109, 110 could be provided withmedicament scrapers 113. The scrapers 113 are suspended at the bottom of thereservoirs 109, 110, such that they bear upon the dose disc 104. The scrapers will passover the openings 108 of the dose disc 104, so that excessive medicament is removedfrom the openings 108, to ensure correct dose volume. Also, the scrapers 113 will aid incompacting medicament in the openings 108, which will improve retention ofmedicament in openings 108 when the dose disc has been rotated into the doseadministering position. Since the scrapers 113 are suspended on the reservoirs 109, 110,they will automatically slide along the upper proximal surface of the dose disc 104,when the dose disc 104 is rotated between the dose administering position and dosecollecting position. Preferably, each reservoir 109, 110 have a number of scrapers 113evenly distributed along the bottom of the reservoirs 109, 110. In this way, the scrapers113 do not only aid in obtaining correct dose volume and dose compacting, but also aidin distributing medicament at the bottom of the reservoirs 109, 110. The number ofscrapers 113 per reservoir 109, 110 could for example be selected in the interval of 1 to6, such as 2 to 4, such as 3. It is also envisioned that the scrapers 113 are arranged in anuneven distribution in the reservoirs 109, 110, if certain reservoirs are configured suchthat an uneven distribution of the scrapers 113 will have a beneficial effect on themedicament distribution along the bottom of the reservoirs 109, 110.

As disclosed in Fig. 7, being a close up cross sectional view of a scraper 113,the scraper 113 could comprise a scraper base portion 113a and a scraper tip portion113b. The scraper base portion 113a is suspended on the reservoirs 109, 110. Thescraper tip portion 113b then extends distally from the scraper base portion 113a. Toincrease efficiency of the scraper 113 with regard to scraping action on the dose disc 104, the base portion 113a could be manufactured of a resilient material. Such a resilient material could for example be a rubber material. The scraper tip portion 113b ishowever preferably made of a plastic material, such as a therrnoplastic material, of thesame kind as the rest of the inhaler 100, such as the dose disc 104, to allow forimproved force attributing characteristics and improved interaction with the edge of theopening 108. The scraper tip portion 113b may be provided with a slanted tip 113c. Theslanted tip 113c further improves interaction with the edge of the opening 108.

During use, the user will then simply rotate the dose disc 104 in one directioninto a dose collecting position if the dose disc is in a dose administering position.Thereafter, the dose disc 104 is rotated preferably into the opposite direction to reachthe dose administering position. If the dose disc 104 is already in the dose collectingposition, of course the first rotation into the dose collecting position may of course beomitted. During these rotations, the scraper 113 will fill the openings 108 of the dosedisc 104 in the reservoirs 109, 110 -the scraper 113 aiding the filling when rotated inboth directions. After the dose disc 104 has been rotated into the dose administeringposition, the openings 108 are filled with medicament - optionally two differentmedicaments - and in ﬂuid communication with the communications 107. Then the userputs his/her mouth at outlet 102 and inhales. During inhalation air A will enter theinhaler 100 through inlets 101 and ﬂow through communications 107 to carry therewiththe medicament(s) M in the openings 108, in accordance with Fig. 8. Theair/medicament ﬂow AM will then enter the chamber 106. In the chamber 106, theair/medicament ﬂows AM from the communications will cross each other, such thatdeaggregation of the medicaments M will increase. Also, the ﬂow characteristics, suchas jet stream formation, will increase. Thereafter, the air/medicament ﬂow AM - nowcomprising air/medicament ﬂows from both communications 107, will go up throughthe inhaler chimney 112 and out into the lungs of the user through outlet 102.

Although, the present invention has been described above with reference tospecific embodiments, it is not intended to be limited to the specific form set forthherein. Rather, the invention is limited only by the accompanying claims.

In the claims, the term “comprises/comprising” does not exclude the presenceof other elements or steps. Furthermore, although individually listed, a plurality ofmeans, elements or method steps may be implemented by e. g. a single unit or processor.Additionally, although individual features may be included in different claims, thesemay possibly advantageously be combined, and the inclusion in different claims doesnot imply that a combination of features is not feasible and/or advantageous. In addition, singular references do not exclude a plurality. The terms “a”, “an”, “first”, lO “second” etc do not preclude a plurality. Reference signs in the clainis are providednierely as a clarifying example and shall not be construed as liniiting the scope of the clainis in any Way.

Claims

1. A dry powder inhaler (100) comprising: at least one inlet (101), at least one Outlet (102), and a dosage communication(107) between said at least one inlet (101) and said at least one outlet (102); a first medicament reservoir (109); a dosage mechanism (104, 108) for arranging at least one dose of amedicament from said first medicament reserVoir (109) between the inlet (101) and theoutlet (102), such that said at least one dose may be delivered upon inhalation at saidoutlet (102), wherein the dosage mechanism (104, 108) comprises a dose disc (104)with at least one opening (108), wherein the dose disc (104) may be rotated between adose collecting position, wherein the opening (108) is positioned in the reservoir (109),and a dose administering position, wherein the opening (108) communicate with saiddosage communication (107); wherein at least one medicament scraper (113) is suspended in the reservoir(109), such that the scraper (113) bear upon the dose disc (104), wherein the dose disc(104) is rotatable in relation to said scraper (113) upon rotation of the dose disc (104).

2. The inhaler (100) according to claim 1, comprising at least a mixing anddeaggregation chamber (106) and at least two dosage communications (107) betweensaid at least one inlet (101) and the chamber (106), wherein the dosage mechanism (104,108) is arranged for arranging the least one dose of a medicament from said firstmedicament reservoir (109) between the inlet (101) and the chamber (106), whereinsaid dosage communications (107) have intersecting directions when entering thechamber (106).

3. The inhaler (100) according to claim 1 or 2, comprising a second medicament reservoir (110) for housing a dry powder secondmedicament; wherein the dosage mechanism (104, 108) is configured to withdraw an inhalermetered dose of the dry powder in the first and second medicament reservoirs (109,110) in the dose collecting position from the reservoirs (109, 110) into said dosage communication (107) in the dose administering position.

4. The inhaler (100) according to claim 3, wherein the dose disc (104) is configured such that a first set of two openings (108) are superimposed the 12 communications (107), While a second set of two openings (108) are positioned in the medicament reservoirs (109, 1 10), respective1y.

5. The inha1er (100) according to c1aim 3, wherein a distribution of theopenings (108) on the dose disc (104) is such that the second set of two openings (108)are superimposed the communications (107) whi1e the first set of openings (108) are positioned in the medicament reservoirs (109, 1 10), respective1y.

6. The inha1er (100) according to c1aim 3 to 5, further comprising at 1east amixing and deaggregation chamber (106) and one dosage communication (107) perreservoir (109, 110), said dosage communications (107) extending from one in1et (101) each to the mixing and deaggregation chamber (106).

7. The inha1er according to c1aim 3 to 6, wherein the dosagecommunications (107) each comprise a 1edge (111) below respective opening (108) in the dose administering position.

8. The inha1er according to any of c1aims 3 to 7, wherein the dosagecommunications (107) are S-shaped between the in1ets (101) and the chamber (106).

9. The inha1er (100) according to any of c1aims 3 to 8, wherein more than one opening (108) per dosage communication (107).

10. The inha1er (100) according to any of c1aims 3 to 9, comprising aninha1ation chimney (112) interconnecting the chamber (106) and the out1et (102).

11. The inha1er (100) according to c1aim 10, wherein the chimney (112) comprises deﬂectors.

12. The inha1er (100) according to any of c1aims 3 to 11, wherein at 1east onemedicament scraper (113) is suspended in each reservoir (109, 110), such that thescraper (113) bear upon the dose disc (104).

13. The inha1er (100) according to c1aim 12, wherein the number of scrapers(113) per reservoir (109, 110) is se1ected in the interva1 from 1 to 6. 13

14. The inha1er (100) according to any of the preceding c1aims, Wherein the number of scrapers (113) in the reservoir (109) is selected in the interval from 1 to 6.

15. The inha1er (100) according to any of the preceding c1aims, Wherein themedicament scraper (113) comprises a scraper base portion (113a) and a scraper tipportion (1 13b).

16. The inha1er (100) according to c1aim 15, Wherein the scraper base portion (113a) is of a resilient material, such as a rubber material.